Live Cell Encapsulation Market Size, Growth, Trends | Report 2023-2032
The global live cell encapsulation market was surpassed at USD 284.12 million in 2022 and is expected to hit around USD 391.2 million by 2032, growing at a CAGR of 3.25% from 2023 to 2032.
Key Pointers
Report Scope of the Live Cell Encapsulation Market
| Report Coverage | Details |
| Market Size in 2022 | USD 284.12 million |
| Revenue Forecast by 2032 | USD 391.2 million |
| Growth rate from 2023 to 2032 | CAGR of 3.25% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | BioTime, Inc., Thermo Fisher Scientific, Merck KGaA, Lonza Group, PromoCell GmbH, STEMCELL Technologies Inc., Corning Incorporated, Merck Millipore, Fujifilm Wako Pure Chemical Corporation, NanoEnTek Inc, and InSphero AG. |
Live cell encapsulation is a process that involves encasing living cells within a protective material or structure. This technology has the potential to revolutionize many areas of research and medicine, as it allows for the safe and controlled delivery of cells and cell-based therapies. There are many different materials and methods used for live cell encapsulation. Some commonly used materials include hydrogels, liposomes, and microcapsules. Hydrogels are hydrophilic, cross-linked polymeric materials that can be made from a variety of natural or synthetic polymers. They are biocompatible and can provide a suitable environment for cell growth and survival. Liposomes, on the other hand, are spherical vesicles composed of a phospholipid bilayer that can encapsulate both hydrophilic and hydrophobic materials. Microcapsules are also spherical structures, but they are composed of a polymeric material that surrounds the cells or active agents.
One of the key advantages of live cell encapsulation is that it allows for the controlled release of cells or bioactive molecules. This is particularly useful in the field of cell-based therapies, where the goal is to deliver therapeutic cells to a specific location in the body while keeping them protected from the host's immune system. For example, live cell encapsulation has been used to deliver insulin-producing cells to patients with diabetes, and it has also been used to deliver cells that produce dopamine to patients with Parkinson's disease. Another area in which live cell encapsulation is being used is tissue engineering. In this field, live cell encapsulation is used to create functional tissue constructs, such as skin, cartilage, and blood vessels, by encapsulating living cells within a supportive material that mimics the extracellular matrix.
The live cell encapsulation market is experiencing growth as a result of increasing investments in new therapeutics and the rise in chronic diseases. The technique of live cell encapsulation involves encasing living cells within a semi-permeable membrane, which can be used to control the delivery of cells in cell transplantation or organ replacement. In addition, BIO INX recently launched a new biocompatible material for live cell encapsulation in November 2022. Compared to protein encapsulation, live cell encapsulation allows for controlled and sustained cell delivery, leading to safe and effective results. In January 2019, BioTime, Inc. launched pluripotent cells which can be used in drug discovery, research, and regenerative medicine therapies, resulting in the company having a better market attention for live cell encapsulation market.
To enable the growth and creation of highly precise and functional microstructure with live cells, BIO INX, a major supplier of biocompatible materials, and Nanoscribe, a leader in microfabrication technology, have expanded their collaboration with the introduction of HYDROBIO INX N400 in November 2022. This product promises to benefit those in the field of live cell encapsulation and regenerative medicine by giving them access to a powerful tool to generate precise, usable, and stable microstructures that contain living cells.
Live Cell Encapsulation Market Segmentations:
| By Polymer Type | By Application | By Technique |
|
Alginate Chitosan Cellulose Sulfate Others |
Drug Delivery Regenerative Medicine Cell Transplantation Probiotics |
Simple Dripping Electrostatic Dripping Coaxial Airflow |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Live Cell Encapsulation Market
5.1. COVID-19 Landscape: Live Cell Encapsulation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Live Cell Encapsulation Market, By Polymer Type
8.1. Live Cell Encapsulation Market, by Polymer Type, 2023-2032
8.1.1 Alginate
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Chitosan
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Cellulose Sulfate
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Live Cell Encapsulation Market, By Application
9.1. Live Cell Encapsulation Market, by Application, 2023-2032
9.1.1. Drug Delivery
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Regenerative Medicine
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Cell Transplantation
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Probiotics
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Live Cell Encapsulation Market, By Technique
10.1. Live Cell Encapsulation Market, by Technique, 2023-2032
10.1.1. Simple Dripping
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Electrostatic Dripping
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Coaxial Airflow
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Live Cell Encapsulation Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by Technique (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Technique (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by Technique (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Technique (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Technique (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Technique (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by Technique (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Technique (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Technique (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Technique (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Technique (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Technique (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Technique (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by Technique (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Technique (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Polymer Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Technique (2020-2032)
Chapter 12. Company Profiles
12.1. BioTime, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck KGaA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Lonza Group
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. PromoCell GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. STEMCELL Technologies Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Corning Incorporated
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merck Millipore
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Fujifilm Wako Pure Chemical Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. NanoEnTek Inc
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers